Robin S Quartin

Title: The Innovative Contributions of Robin S Quartin

Introduction

Robin S Quartin is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of nucleotide compounds, holding a total of 3 patents. His work focuses on developing modified nucleotide compounds that have potential applications in various biotechnological fields.

Latest Patents

One of Quartin's latest patents is for a modified nucleotide compound. This invention discloses a nuclease-resistant nucleotide compound capable of hybridizing with a complementary RNA in a manner that inhibits its function. The modified nucleotide compound includes components selected from the group consisting of MNM, B(N)M, and M(N)B, where N is a phosphodiester-linked modified 2'-deoxynucleoside moiety. M confers endonuclease resistance, while B provides exonuclease resistance to the terminus to which it is attached. Another significant patent involves nucleic acid displacer compositions and cells comprising the same. This patent outlines procedures and compositions for forming and stabilizing non-stable branch-migrated oligo- and polydeoxynucleotides utilizing a displacer that may contain one or more modified nucleotides.

Career Highlights

Throughout his career, Quartin has worked with prominent companies such as Enzo Therapeutics, Inc. and Enzo Life Sciences, Inc. His experience in these organizations has allowed him to further his research and development in the field of nucleotide compounds.

Collaborations

Quartin has collaborated with notable individuals in his field, including James G Wetmur and Dean L Engelhardt. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robin S Quartin's innovative work in the field of nucleotide compounds has led to significant advancements and holds promise for future applications. His contributions continue to impact the biotechnology sector positively.